Brian Werneburg, PhD, is affiliated with Sage Therapeutics, Inc, in Cambridge, Massachusetts. Werneburg has published research focused on major depressive disorder (MDD) and its associated comorbidities, including systematic literature reviews examining the impact of treating depression on related health conditions. Contributions span from 2022 to 2023 in Psychiatrist.com, collaborating frequently with co-authors such as Alix M. Arnaud and Ken Duckworth.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
